New study tests tailored Weight-Loss program for obesity

NCT ID NCT07465341

Recruiting now Disease control Sponsor: University of Michigan Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a program called MiWeigh that helps people with obesity and related conditions like diabetes or high blood pressure lose weight. Participants get a personalized plan from a doctor, access to a website, and weekly check-ins. The goal is to see if this approach leads to more weight loss than just giving people information.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: behavioral intervention: personalized weight-loss program with doctor visits and weekly check-ins
What this could lead to: If successful, this program could offer a practical, scalable way for healthcare systems to help people with obesity lose weight and manage related health issues.
What could go wrong: This is a behavioral study, not a drug trial, so results depend on participant motivation. It is still recruiting and outcomes are measured at 12 months, so long-term effects are unknown.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPERLIPIDEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hyperlipidemia hypertensive disorder metabolic dysfunction-associated steatotic liver disease Obesity obesity disorder obstructive sleep apnea syndrome polycystic ovary syndrome prediabetes syndrome type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

OBESITY

Contacts and locations

Locations

University of Michigan
RECRUITING

Ann Arbor, Michigan, 48109, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.